A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Clinical trial NCT01461993 · COMPLETED

Trial details

NCT number: NCT01461993
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Vaccines Meningococcal Vaccines

Start date: 2011-09-28
Primary completion: 2013-07-06
Enrollment: 2499

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.